Connor, Clark & Lunn Investment Management (CC&L)’s Minerva Neurosciences NERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-17,970
| Closed | -$250K | – | 1161 |
|
|
2021
Q3 | $250K | Buy |
17,970
+4,486
| +33% | +$62.4K | ﹤0.01% | 910 |
|
|
2021
Q2 | $250K | Buy |
13,484
+1,261
| +10% | +$23.4K | ﹤0.01% | 879 |
|
|
2021
Q1 | $286K | Buy |
12,223
+3,770
| +45% | +$88.2K | ﹤0.01% | 873 |
|
|
2020
Q4 | $158K | Buy |
+8,453
| New | +$158K | ﹤0.01% | 841 |
|
|
2020
Q2 | – | Sell |
-12,107
| Closed | -$583K | – | 1130 |
|
|
2020
Q1 | $583K | Sell |
12,107
-5,190
| -30% | -$250K | 0.01% | 659 |
|
|
2019
Q4 | $984K | Sell |
17,297
-619
| -3% | -$35.2K | 0.01% | 547 |
|
|
2019
Q3 | $1.11M | Buy |
17,916
+7,607
| +74% | +$472K | 0.01% | 524 |
|
|
2019
Q2 | $464K | Buy |
+10,309
| New | +$464K | ﹤0.01% | 736 |
|